4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-007774
CVP, TAVR sold 619 shares at $87.51 ($54,169)
- CVP, TAVR acquired 619 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lippis Daniel J. CVP, TAVR | 2026-09-11 | Option exercise 10b5-1 | +619 | $72.68 | $44,989 | 40,652.91 | D |
| Lippis Daniel J. CVP, TAVR | 2026-09-11 | Sale 10b5-1 | −619 | $87.51 | $54,169 | 40,033.91 | D |
| Derivatives | |||||||
| Lippis Daniel J. CVP, TAVR | 2026-09-11 | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 3,714 | D | ||
| Open-market sales · 619 sh · avg $87.51 · $54,169 | |||||||
Loading xslF345X06/doc4.xml…